BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34592193)

  • 21. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.
    Butcher NJ; Mew EJ; Monsour A; Chan AW; Moher D; Offringa M
    Trials; 2020 Jul; 21(1):620. PubMed ID: 32641085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
    Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krle A-Jerić K; Hrobjartsson A; Mann H; Dickersin K; Berlin JA; Dore CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
    Rev Panam Salud Publica; 2015 Dec; 38(6):506-14. PubMed ID: 27440100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
    Solovyeva O; Dimairo M; Weir CJ; Hee SW; Espinasse A; Ursino M; Patel D; Kightley A; Hughes S; Jaki T; Mander A; Evans TRJ; Lee S; Hopewell S; Rantell KR; Chan AW; Bedding A; Stephens R; Richards D; Roberts L; Kirkpatrick J; de Bono J; Yap C
    BMC Med; 2023 Jul; 21(1):246. PubMed ID: 37408015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
    Chan AW; Tetzlaff JM; Gøtzsche PC; Altman DG; Mann H; Berlin JA; Dickersin K; Hróbjartsson A; Schulz KF; Parulekar WR; Krleza-Jeric K; Laupacis A; Moher D
    BMJ; 2013 Jan; 346():e7586. PubMed ID: 23303884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
    Kyte D; Duffy H; Fletcher B; Gheorghe A; Mercieca-Bebber R; King M; Draper H; Ives J; Brundage M; Blazeby J; Calvert M
    PLoS One; 2014; 9(10):e110229. PubMed ID: 25333349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study.
    Tan ZW; Tan AC; Li T; Harris I; Naylor JM; Siebelt M; van Tiel J; Pinheiro M; Harris L; Chamberlain K; Adie S
    BMJ Open; 2020 Aug; 10(8):e038283. PubMed ID: 32847919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
    Calvert M; King M; Mercieca-Bebber R; Aiyegbusi O; Kyte D; Slade A; Chan AW; Basch E; Bell J; Bennett A; Bhatnagar V; Blazeby J; Bottomley A; Brown J; Brundage M; Campbell L; Cappelleri JC; Draper H; Dueck AC; Ells C; Frank L; Golub RM; Griebsch I; Haywood K; Hunn A; King-Kallimanis B; Martin L; Mitchell S; Morel T; Nelson L; Norquist J; O'Connor D; Palmer M; Patrick D; Price G; Regnault A; Retzer A; Revicki D; Scott J; Stephens R; Turner G; Valakas A; Velikova G; von Hildebrand M; Walker A; Wenzel L
    BMJ Open; 2021 Jun; 11(6):e045105. PubMed ID: 34193486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension.
    Liu X; Rivera SC; Moher D; Calvert MJ; Denniston AK;
    BMJ; 2020 Sep; 370():m3164. PubMed ID: 32909959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study protocol for the development of a SPIRIT extension for trials conducted using cohorts and routinely collected data (SPIRIT-ROUTINE).
    McCarthy M; O'Keeffe L; Williamson PR; Sydes MR; Farrin A; Lugg-Widger F; Davies G; Avery K; Chan AW; Kwakkenbos L; Thombs BD; Watkins A; Hemkens LG; Gale C; Zwarenstein M; Langan SM; Thabane L; Juszczak E; Moher D; Kearney PM
    HRB Open Res; 2021; 4():82. PubMed ID: 34877471
    [No Abstract]   [Full Text] [Related]  

  • 30. Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018).
    Dai L; Cheng CW; Tian R; Zhong LL; Li YP; Lyu AP; Chan AW; Shang HC; Bian ZX
    Chin J Integr Med; 2019 Jan; 25(1):71-79. PubMed ID: 30484022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects.
    Gryaznov D; Odutayo A; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Blümle A; Schandelmaier S; Mertz D; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Bischoff K; Wollmann K; Rehner L; Lohner S; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Heravi AT; Wong J; Chow N; Hong PJ; Cord KM; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens LG; Hopewell S; von Elm E; Briel M
    Trials; 2020 Oct; 21(1):896. PubMed ID: 33115541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not enough SPIRIT shown in the registration and reporting of orthodontic trial protocols.
    Eleftheriadi I; Ioannou T; Katechi V; Seehra J; Pandis N
    Eur J Orthod; 2023 Feb; 45(1):29-37. PubMed ID: 35639885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
    Orkin AM; Gill PJ; Ghersi D; Campbell L; Sugarman J; Emsley R; Steg PG; Weijer C; Simes J; Rombey T; Williams HC; Wittes J; Moher D; Richards DP; Kasamon Y; Getz K; Hopewell S; Dickersin K; Wu T; Ayala AP; Schulz KF; Calleja S; Boutron I; Ross JS; Golub RM; Khan KM; Mulrow C; Siegfried N; Heber J; Lee N; Kearney PR; Wanyenze RK; Hróbjartsson A; Williams R; Bhandari N; Jüni P; Chan AW;
    JAMA; 2021 Jul; 326(3):257-265. PubMed ID: 34152382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines.
    Cruz Rivera S; Aiyegbusi OL; Ives J; Draper H; Mercieca-Bebber R; Ells C; Hunn A; Scott JA; Fernandez CV; Dickens AP; Anderson N; Bhatnagar V; Bottomley A; Campbell L; Collett C; Collis P; Craig K; Davies H; Golub R; Gosden L; Gnanasakthy A; Haf Davies E; von Hildebrand M; Lord JM; Mahendraratnam N; Miyaji T; Morel T; Monteiro J; Zwisler AO; Peipert JD; Roydhouse J; Stover AM; Wilson R; Yap C; Calvert MJ
    JAMA; 2022 May; 327(19):1910-1919. PubMed ID: 35579638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study.
    Lohner S; Gryaznov D; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Schandelmaier S; Mertz D; Odutayo A; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Heravi AT; Wong J; Chow N; Hong PJ; McCord K; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens LG; Hopewell S; von Elm E; Blümle A; Briel M
    J Clin Epidemiol; 2021 Nov; 139():340-349. PubMed ID: 34029678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.
    Speich B; Odutayo A; Peckham N; Ooms A; Stokes JR; Saccilotto R; Gryaznov D; von Niederhäusern B; Copsey B; Altman DG; Briel M; Hopewell S
    Trials; 2022 Jul; 23(1):601. PubMed ID: 35897110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing an international consensus Reporting guideline for intervention Fidelity in Non-Drug, non-surgical trials: The ReFiND protocol.
    Sousa Filho LF; Farlie MK; Haines T; Borrelli B; Carroll C; Mathews C; Ribeiro DC; Fritz JM; Underwood M; Foster NE; Lamb SE; Sanchez ZM; Malliaras P
    Contemp Clin Trials; 2024 Jul; 142():107575. PubMed ID: 38750951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.
    Kyte D; Retzer A; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Turner G; Calvert M
    J Natl Cancer Inst; 2019 Nov; 111(11):1170-1178. PubMed ID: 30959516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.
    King MT; Tait MA; Campbell R; Müller F; Rutherford C; Beckmore C; Chima S; Langbecker D; Shaw J; Mercieca-Bebber R
    Qual Life Res; 2022 Oct; 31(10):2901-2916. PubMed ID: 35553325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
    Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.